Bruker BioSciences, Thermo Electron, NCI, Stratagene, Molecular Devices, Serologicals | GenomeWeb

Bruker CEO Takes 20 Percent Pay Cut in ‘05 As Company Seeks $3M A Year Savings

Bruker BioSciences announced another round of cost-cutting and restructuring on Monday to save the company $3 million a year, and another $1 million next year.

Bruker will move all its German administrative and life science business activities to its site in Bremen, and its German nuclear, biological, and chemical detection business to its Leipzig site. Moreover, the UK operations of subsidiaries Bruker AXS and Bruker Daltonics will be combined into one, based in Coventry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.